Clinical Trials Logo

Clinical Trial Summary

The aim of the randomized controlled interventional study was to to evaluate the effect of human care model-based nursing interventions on psychosocial adaptation in patients with cardioverter defibrillator. A study was carried out on a sample of 64 patients who had been implanted with a defibrillator. The intervention group participants underwent six interviews at two-week intervals, during which a hybrid and structured nursing intervention was administered.


Clinical Trial Description

Aim: The aim of this research was to investigate the impact of nursing interventions that were Watson's Human Care Model- based nursing interventions on the psychosocial adjustment of patients who have undergone implantable cardioverter defibrillator (ICD) implantation. Design: The present study employs a randomized controlled design with a pretest-posttest control group, conducted over a period spanning from March 2020 to July 2022. Methods: The research was carried out utilizing an implantable cardioverter on individuals who met the inclusion criteria and provided consent to participate in the study at an adult cardiology outpatient unit located within a university hospital. A study was carried out on a sample of 64 patients who had been implanted with a defibrillator. The intervention group participants underwent six interviews at two-week intervals, during which a hybrid and structured nursing intervention was administered. The data were gathered utilizing an introductory information form and the Psychosocial Adjustment to Illness-Self-Report Scale (PAIS-SR). The statistical methods employed in the data analysis included the chi-square test, t test for independent groups, Mann-Whitney U test, t test for dependent groups, and Wilcoxon signed-rank test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05959993
Study type Interventional
Source Ege University
Contact
Status Completed
Phase N/A
Start date March 1, 2020
Completion date July 7, 2022

See also
  Status Clinical Trial Phase
Completed NCT04070300 - Physical Activity and Ventricular Arrhythmias N/A
Completed NCT04075253 - Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia N/A
Completed NCT00522340 - Exercise After an ICD Phase 2
Completed NCT00157820 - DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study N/A
Active, not recruiting NCT01138670 - Complications Following Pacemaker or Implantable Defibrillator Cardioverter (ICD) Implantation in Denmark N/A
Completed NCT05366660 - Remote Programming of Cardiac Implantable Electronic Device N/A
Completed NCT01043562 - Precise Measurement of Pediatric Defibrillation Thresholds N/A
Terminated NCT01258283 - PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator? N/A
Completed NCT03579641 - Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
Recruiting NCT03061747 - Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored N/A
Completed NCT00498524 - Risk of Life-threatening Heart Rhythm Disturbances in Siblings N/A
Recruiting NCT00356239 - Implantable Cardioverter Defibrillators And Magnetic Resonance Imaging of the Heart at 1.5 Tesla N/A
Withdrawn NCT00507390 - Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia Phase 4
Completed NCT00598026 - Evaluation of the " Tele-follow-up " for the Follow-up of Implantable Defibrillators N/A
Completed NCT03271619 - Electrical Safety of Implantable Cardioverter Defibrillators N/A
Recruiting NCT06330675 - Correct Mobilization Time After CIED Implantation: A Single-centre, Open-label, Non-inferiority RCT N/A
Completed NCT00845390 - Patient Expectations After Implantable-cardioverter Defibrillator (ICD) Implantation
Recruiting NCT02882139 - International Electrical Storm Registry
Terminated NCT01097330 - Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia Phase 3